Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Jacobs L < Jacobs M < Jacobs S

Michael Jacobs
. co-senior author.
000290
Remdesivir, hydroxychloroquine, and lopinavir-ritonavir panel member.
000C90
Royal Free London NHS Foundation Trust rochwerg@mcmaster.ca michael.jacobs@ucl.ac.uk.
000C90
Royal Free London NHS Foundation Trust, London, UK francois.lamontagne@usherbrooke.ca michael.jacobs@ucl.ac.uk.
000290
co-senior author.
000C90
ivermectin panel member.
000C90

<g>
<k>Jacobs M</k>
<l>
<g>
<k>Michael Jacobs</k>
<l>
<g>
<k>
<nlm:affiliation>. co-senior author.</nlm:affiliation>
</k>
<l>
<i>000290</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Remdesivir, hydroxychloroquine, and lopinavir-ritonavir panel member.</nlm:affiliation>
</k>
<l>
<i>000C90</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Royal Free London NHS Foundation Trust rochwerg@mcmaster.ca michael.jacobs@ucl.ac.uk.</nlm:affiliation>
</k>
<l>
<i>000C90</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Royal Free London NHS Foundation Trust, London, UK francois.lamontagne@usherbrooke.ca michael.jacobs@ucl.ac.uk.</nlm:affiliation>
</k>
<l>
<i>000290</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>co-senior author.</nlm:affiliation>
</k>
<l>
<i>000C90</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>ivermectin panel member.</nlm:affiliation>
</k>
<l>
<i>000C90</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>6</n>
<t>6</t>
</g>
</l>
<n>1</n>
<t>6</t>
</g>

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021